Standard BioTools Inc. (NASDAQ:LAB) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET
Company Participants
David Holmes - IR
Michael Egholm - President and CEO
Jeff Black - CFO
Conference Call Participants
Matt Stanton - Jefferies
Dan Brennan - TD Cowen
Paul Knight - KeyBanc
Operator
Good day and welcome to the Standard BioTools Second Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being recorded.
I would now like to turn the conference over David Holmes of Investor Relations. Please go ahead.
David Holmes
Thank you, operator and good afternoon, everyone. Welcome to Standard BioTools' second quarter 2024 earnings conference call. Leading the call today is Michael Egholm, President and Chief Executive Officer; and Jeff Black, Chief Financial Officer.
At the close of market today, Standard BioTools released its financial results for the quarter ended June 30, 2024. During the call, we will review our results and provide an update on our financial and operational performance, 2024 outlook, market trends, and strategic initiatives.
During the call, we will be making forward-looking statements about events and circumstances that have not yet occurred, including plans and projections of our business, our outlook for 2024 and future financial results, market trends and opportunities, our expectations related to the combined operations with SomaLogic, including potential synergies, and our business outlook for the combined company.
These statements are subject to substantial risks and uncertainties that may cause actual events or results to differ materially from current expectations. The forward-looking statements on this call are based on information currently available to us and we disclaim any obligation to update these statements, except as may be required by law.
During the call, we will also present some financial information on a non-GAAP basis. We believe these non-GAAP financial measures are useful in evaluating our core performance and as a baseline for assessing the future earnings potential of the company. We use these non-GAAP measures in our own evaluation of continuing operating performance.
We encourage you to carefully consider our results on a GAAP and non-GAAP basis. A reconciliation between non-GAAP measures and their GAAP equivalents are provided in the tables accompanying today's press release and as an appendix to today's presentation slides. Please note that management will be referring to a slide presentation, including updated supplemental financial information within the webcast today.
Following prepared remarks, we will host a Q&A session. Today's presentation will be available on the website as well as the webcast on the Investor Relations section of the website.